C41H47BrF3N9O — CID 155308251
6-bromo-3-[1-[5-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]pentyl]pyrazol-4-yl]-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 155308251) has the molecular formula C41H47BrF3N9O and a molecular weight of 818.79 g/mol. Its IUPAC name is 6-bromo-3-[1-[5-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]pentyl]pyrazol-4-yl]-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine.
| Compound Name | 6-bromo-3-[1-[5-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]pentyl]pyrazol-4-yl]-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine |
|---|---|
| PubChem CID | 155308251 |
| Molecular Formula | C41H47BrF3N9O |
| Molecular Weight | 818.79 g/mol |
| Exact Mass | 817.30 |
| IUPAC Name | 6-bromo-3-[1-[5-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]pentyl]pyrazol-4-yl]-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine |
| SMILES | C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(OCCCCCn3cc(-c4cnn5c(N)c(Br)c([C@@H]6CCCNC6)nc45)cn3)cc2F)N1CC(C)(C)F |
| InChI | InChI=1S/C41H47BrF3N9O/c1-24-16-29-28-11-5-6-12-33(28)50-37(29)38(53(24)23-41(2,3)45)34-31(43)17-27(18-32(34)44)55-15-8-4-7-14-52-22-26(20-48-52)30-21-49-54-39(46)35(42)36(51-40(30)54)25-10-9-13-47-19-25/h5-6,11-12,17-18,20-22,24-25,38,47,50H,4,7-10,13-16,19,23,46H2,1-3H3/t24-,25-,38-/m1/s1 |
| InChIKey | YWALZDQSXYBBGT-VFRCCXMQSA-N |
| XLogP | 8.50 |
| TPSA | 114.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 55 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 818.79 |
| LogP ≤ 5 | 8.50 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|